Post by trueblue on Aug 31, 2022 23:02:12 GMT
'FDA authorizes reformulated COVID-19 booster shot for the fall'
The Food and Drug Administration on Wednesday paved the way for a new COVID-19 booster that could be available within days.
The FDA gave emergency authorization to a "bivalent" vaccine that targets both the original virus and the BA.4 and BA.5 variants that now dominate the world.
An advisory committee to the Centers for Disease Control and Prevention is scheduled to meet Thursday to discuss who should receive the boosters. The CDC director will also need to sign off before the boosters become available.
As requested by the companies, the Pfizer-BioNTech booster was authorized for anyone ages 12 and up, while Moderna's vaccine is authorized for adults only. Both were authorized for use at least two months after any previous COVID-19 shots.
The FDA gave emergency authorization to a "bivalent" vaccine that targets both the original virus and the BA.4 and BA.5 variants that now dominate the world.
An advisory committee to the Centers for Disease Control and Prevention is scheduled to meet Thursday to discuss who should receive the boosters. The CDC director will also need to sign off before the boosters become available.
As requested by the companies, the Pfizer-BioNTech booster was authorized for anyone ages 12 and up, while Moderna's vaccine is authorized for adults only. Both were authorized for use at least two months after any previous COVID-19 shots.